作者
Jerome R Lechien, Carlos M Chiesa‐Estomba, Sammy Place, Yves Van Laethem, Pierre Cabaraux, Quentin Mat, Kathy Huet, Jan Plzak, Mihaela Horoi, Stéphane Hans, Maria Rosaria Barillari, Giovanni Cammaroto, Nicolas Fakhry, Delphine Martiny, Tareck Ayad, Lionel Jouffe, Claire Hopkins, Sven Saussez, COVID‐19 Task Force of YO‐IFOS, Serge Blecic, Daniele R De Siati, Pierre Leich, Christel Souchay, Camelia Rossi, Fabrice Journe, Julien Hsieh, Laurence Ris, Fahd El Afia, Bernard Harmegnies, Lea Distinguin, Younes Chekkoury‐Idrissi, Marta Circiu, Philippe Lavigne, Irene Lopez Delgado, Christian Calvo‐Henriquez, Chiara Falanga, Frederique Coppee, Serge Daniel Le Bon, Alexandra Rodriguez, Didier Dequanter, Jean‐Philippe Cornelis, Sebastien Vergez, Lukas Koenen, Mannelli Giuditta, Gabriele Molteni, Manuel Tucciarone, Thomas Radulesco, Mohamad Khalife, Anne‐Francoise Fourneau, Soraya Cherifi, Mario Manto, Justin Michel, Thomas Radulesco, Gabriele Molteni, Manuel Tucciarone, Giuditta Mannelli, Giovanna Cantarella
发表日期
2020/9
期刊
Journal of internal medicine
卷号
288
期号
3
页码范围
335-344
简介
Background
The clinical presentation of European patients with mild‐to‐moderate COVID‐19 infection is still unknown.
Objective
To study the clinical presentation of COVID‐19 in Europe.
Methods
Patients with positive diagnosis of COVID‐19 were recruited from 18 European hospitals. Epidemiological and clinical data were obtained through a standardized questionnaire. Bayesian analysis was used for analysing the relationship between outcomes.
Results
A total of 1,420 patients completed the study (962 females, 30.7% of healthcare workers). The mean age of patients was 39.17 ± 12.09 years. The most common symptoms were headache (70.3%), loss of smell (70.2%), nasal obstruction (67.8%), cough (63.2%), asthenia (63.3%), myalgia (62.5%), rhinorrhea (60.1%), gustatory dysfunction (54.2%) and sore throat (52.9%). Fever was reported by 45.4%. The mean duration of COVID‐19 symptoms of mild‐to …
引用总数